Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.44 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.44 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.44 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.44 |
| ▸ | MMP9 | P14780 | 7/20 | 0.43 |
| ▸ | MMP2 | P08253 | 6/20 | 0.43 |
| ▸ | MMP8 | P22894 | 4/20 | 0.43 |
| ▸ | MMP13 | P45452 | 4/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | MMP3 | P08254 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2887982 | 0.90 | LMNA (0.64) | LMNAALDH1A1KDM4ECYP3A4GABRB3 | |
| Butethal SCHEMBL44262 | 0.86 | LMNA (0.67) | LMNAALDH1A1KDM4ECYP3A4GABRB3 | |
| Barbital SCHEMBL7348703 | 0.85 | LMNA (0.90) | LMNAALDH1A1KDM4ECYP3A4GABRB3 | |
| Barbital SCHEMBL3859278 | 0.85 | LMNA (1.00) | LMNAALDH1A1KDM4ECYP3A4GABRB3 | |
| Barbital SCHEMBL43818 | 0.85 | LMNA (1.00) | LMNAALDH1A1KDM4ECYP3A4GABRB3 | |
| SCHEMBL918796 | 0.85 | LMNA (0.64) | LMNAALDH1A1KDM4ECYP3A4GABRB3 | |
| Butethal SCHEMBL2718536 | 0.85 | LMNA (0.64) | LMNAALDH1A1KDM4ECYP3A4GABRB3 | |
| Barbital SCHEMBL8746543 | 0.83 | LMNA (0.85) | LMNAALDH1A1KDM4ECYP3A4GABRB3 | |
| SCHEMBL4382583 | 0.83 | MMP9 (0.63) | LMNAALDH1A1KDM4ECYP3A4GABRB3 | |
| SCHEMBL4379822 | 0.83 | MMP9 (0.63) | LMNAALDH1A1KDM4ECYP3A4GABRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260013535-A1 | STEVIOL GLYCOSIDE SOLUBILITY ENHANCERS | CARGILL, INCORPORATED (US) | 2026-01-15 | — | — | US | disclosed |
| US-11717549-B2 | Steviol glycoside solubility enhancers | CARGILL, INCORPORATED (US) | 2023-08-08 | — | — | US | disclosed |
| US-20220323528-A1 | STEVIOL GLYCOSIDE SOLUBILITY ENHANCERS | CARGILL, INCORPORATED (US) | 2022-10-13 | — | — | US | disclosed |
| US-20190223481-A1 | STEVIOL GLYCOSIDE SOLUBILITY ENHANCERS | CARGILL, INCORPORATED (US) | 2019-07-25 | — | — | US | disclosed |
| US-20080104001-A1 | ALGORITHM FOR ESTIMATION OF BINDING EQULIBRIA IN INCLUSION COMPLEXATION, HOST COMPOUNDS IDENTIFIED THEREBY AND COMPOSITIONS OF HOST COMPOUND AND PHARMACEUTICAL | BAXTER INTERNATIONAL INC. | 2008-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260013535-A1 | STEVIOL GLYCOSIDE SOLUBILITY ENHANCERS | TAS2R7, TAS2R31, TAS2R40 | LMNA 4221/4885ALDH1A1 3539/4885KDM4E 3473/4885 |
| US-20220323528-A1 | STEVIOL GLYCOSIDE SOLUBILITY ENHANCERS | SI, TAS2R7, TAS2R31 | LMNA 4020/4885ALDH1A1 2625/4885KDM4E 3664/4885 |
| US-11717549-B2 | Steviol glycoside solubility enhancers | SI, TAS2R7, TAS2R31 | LMNA 4020/4885ALDH1A1 2625/4885KDM4E 3664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.